“…While Europe and North America argue the ethics and cost effectiveness of marginal benefits of screening programmes, evidence is emerging from high quality, population-based studies in South America that congenital toxoplasmosis is a major public health problem (BahiaOliveira et al 2001, Neto et al 2004, Portela et al 2004, Gomez-Marin et al 2007, Lago et al 2007, Andrade et al 2008. Moreover, these clinician researchers are demonstrating that they can implement neonatal screening and follow up programmes to the high standards of quality that need to be reached before screening can be considered a feasible option.…”